University of Wisconsin–Madison

Pharmacy Invitational Conference on Antithrombotic Therapy (PICAT)

Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

blood cellsThis program is designed to provide pharmacists with current information on antithrombotic therapies and to increase their knowledge and skills required to promote the appropriate management of patients.

This conference is made possible in part through educational grants from:
Portillo

Registration Information

Register

Refund Policy

Course date:Dec 7, 2019
Location:

Tropicana
3801 Las Vegas Boulevard South
Las Vegas, NV

Course fee:

$150 early registration
$225 after November 23, 2019

The program fee includes continental breakfast, lunch, breaks, instruction and CE credit.

Refund policy: A refund minus a $45 administrative fee will be provided up to November 23, 2019. After Novemeber 23, no refunds will be provided.

Course Objectives

This program is designed to provide pharmacists with current information on antithrombotic therapy and to increase their knowledge and skills required to promote the appropriate management of patients. Upon completion of the program, the learner should be able to:

  • Critique recent antithrombotic clinical trial results and their impact on practice;
  • Discuss incorporating DOACs into clinical practices in the ambulatory care setting;
  • Describe an individualized stepwise approach to managing the burden of illness of antithrombotic associated hemorrhage with reversal and treatment strategies, taking into consideration the site of and additional risk factors for bleeding, the expected duration of anticoagulant effect and appropriate reversal agent selection, including new and investigational DOAC reversal agents;
  • Compare and contrast consensus recommendations for the use of the various reversal agents for emergency invasive procedures in patients on antithrombotic therapy;
  • Discuss the development of institution-specific guidelines, and policies and procedures for the use of antithrombotic reversal agents for emergency surgery and for the management of severe bleeding;
  • Describe the impact of peripheral artery disease (PAD) on cardiovascular outcomes and determine the optimal antithrombotic regimen for these patients based on their clinical scenario and a review of the literature;
  • Describe the recommended place in therapy of DOACs for the treatment and prevention of venous thromboembolic disease, including their use in specific acquired and hereditary hypercoagulable states, and describe appropriate agent and dose selection using an individualized patient approach;
  • Describe the consequences of lack of adherence to DOACs, including strategies to improve adherence rates;
  • Summarize what is known about extended medical VTE prophylaxis and what strategies may be effective, and identify how DOAC levels can be helpful in managing patients who have significant bleeding events and VTE risk factors;
  • Complete an individualized risk assessment for anticoagulation management in the periprocedural setting and develop a plan for anticoagulation in the periprocedural setting; and
  • Identify common cardiovascular procedures and devices and provide recommendations for managing anticoagulation for these patients.

Course Outline

December 7, 2019

7:00 am

Registration and Continental Breakfast

8:00 am

Welcome and Introductions
Brett Kelly, BS Pharm, MS
Conference Coordinator, Clinical Assistant Professor, UW-Madison School of Pharmacy

Cynthia Jackevicius, PharmD, MSc, BCPS-AQ Cardiology, BCCP, FCSHP, FAHA, FCCP, FCCS, FACC
Program Chair and Morning Moderator, Western University of Health Sciences

8:10 am

2019 Clinical Year in Review
Speaker: Scott Kaatz, DO, MSc, FACP, SFHM, Clinical Associate Professor of Medicine - Wayne State University, Senior Staff Hospitalist, Medical Director for Professional Development and Research, Division of Hospital Medicine, Henry Ford Hospital

8:55 am

Discussion

9:00 am

Insights on Antithrombotic Therapy with Devises & Post Proceduaral Management of Antithrombotic Therapy in the Hardware Era
Speakers: Janet Han, MD, FACC, FHRS, Associate Professor of Medicine, University of California Los Angeles, Cardiac Electrophysiology, VA Greater Los Angeles Healthcare System
and
Anne Rose, PharmD, Pharmacy Manager, UW Health, University of Wisconsin Hospitals and Clinics

10:00 am

Discussion

10:10 am

Break

10:30am

Joint Commission Patient Safety Goals and Anticoagulation Stewardship

Moderator: Scott Kaatz, DO, MSc, FACP, SFHM

Speaker 1: Allison Burnett, PharmD, PhC, CACP, Antithrombosis Stewardship Pharmacist, University of New Mexico Hospital, President Elect, Anticoagulation Forum

Speaker 2: Anne Rose, PharmD, University of Wisconsin Hospitals and Clinics

11:30 am

Discussion

12:00 pm

Lunch

1:00 pm

Welcome to the Afternoon Session
Andrea L. Porter, PharmD
Conference Chair and Afternoon Moderator, Associate Professor (CHS), University of Wisconsin-Madison, School of Pharmacy

1:05 pm

Debate Over Reversal Agents for Oral Direct Xa Inhibitors in Life Threatening Bleeding (Pros and Cons of Andexanet vs. 4 Factor PC)
Moderator: Michael Gulseth, PharmD, Program Director for Anticoagulation Services, Department of Pharmaceutical Services, Sanford USD Medical Center

Speaker 1: T. Milling Jr., MD, FACEP, Associate Professor, Department of Neurology, Department of Surgery and Perioperative Care, University of Texas-Austin, Dell Medical School

Speaker 2: Lynda Thomson, PharmD, Clinical Pharmacists, Thomas Jefferson University

1:50 pm

Discussion

2:00 pm

Streamlining Antiplatelet Therapy after PCI in Chronically Anticoagulated Patients

Speaker: David Parra, PharmD, FCCP, Clinical Pharmacy Program Manager in Cardiology & Anticoagulation, VISN 8 Pharmacy Benefits Management, Department of Veterans Affairs

2:30 pm

Discussion

2:40 pm

Break

3:00 pm

VTE and Cancer
Speaker: Jennifer L. Hedgecorth, PharmD, BCPS, Clinical Pharmacist, Washington University School of Medicine, Siteman Cancer Center

3:30 pm

Discussion

3:35 pm

Case Studies: HIT
Speaker: Maureen Smythe, PharmD, FCCP, Professor (Clinical), Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, William Beaumont Hospital

3:55 pm

Discussion

4:00 pm

Making Decisions in Special Patient Populations-Renal Disease and Drug Interactions

Renal Disease
Speaker: Charles (Kurt) Mahan, PharmD, PhC, FCCP, FASHP, Adjunct Professor of Pharmacy, Cardiac Critical Care Pharmacist, Presbyterian Healthcare Services, University of New Mexico College of Pharmacy

DOAC Drug Interactions
Speaker: Candice Garwood, PharmD, FCCP, BCPS, BCACP, Professor (Clinical), Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University

4:45 pm

Discussion on Special Populations

4:55 pm

Open Discussion/Closing comments

5:00 pm

Adjourn

Instructors

Allison Burnett, PharmD, PhC, CACP, Antithrombosis Stewardship Pharmacist, University of New Mexico Hospital, President Elect, Anticoagulation Forum, Newton, MA

Candice Garwood, PharmD, FCCP, BCPS, BCACP, Professor (Clinical), Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI

Michael P. Gulseth, PharmD, BCPS, FASHP, Program Director for Anticoagulation Services, Department of Pharmaceutical Services, Sanford USD Medical Center, Clinical Associate Professor of Internal Medicine, University of South Dakota Sanford School of Medicine, President, Michael P. Gulseth Anticoagulation Consulting, Inc., Sioux Falls, South Dakota

Janet Han, MD, FACC, FHRS, Associate Professor of Medicine, University of California Los Angeles, Cardiac Electrophysiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA

Jennifer L. Hedgecorth, PharmD, BCPS, Clinical Pharmacist, Washington University School of Medicine, Siteman Cancer Center, St. Louis, MO

Cynthia Jackevicius, BScPhm, PharmD, MSc, FCSHP, BCPS, Professor of Pharmacy Practice and Administration, Western University of Health Sciences College of Pharmacy, VA Greater Los Angeles Healthcare System, Los Angeles, California

Scott Kaatz, DO, MSc, FACP, SFHM, Clinical Associate Professor of Medicine - Wayne State University, Senior Staff Hospitalist, Medical Director for Professional Development and Research, Division of Hospital Medicine, Henry Ford Hospital, Detroit, Michigan

Brett Kelly, MS, BS Pharm, Conference Coordinator, Clinical Assistant Professor, University of Wisconsin‐Madison School of Pharmacy, Madison, Wisconsin

Charles (Kurt) Mahan, PharmD, PhC, FCCP, FASHP, Adjunct Professor of Pharmacy, Cardiac Critical Care Pharmacist, Presbyterian Healthcare Services, University of New Mexico College of Pharmacy, Albuquerque, New Mexic

T. Milling Jr., MD, FACEP, Associate Professor, Department of Neurology, Department of Surgery and Perioperative Care, University of Texas-Austin, Dell Medical School

David Parra, PharmD, FCCP, Clinical Pharmacy Program Manager in Cardiology & Anticoagulation, VISN 8 Pharmacy Benefits Management, Department of Veterans Affairs, Bay Pines, FL

Andrea L. Porter, PharmD, Conference Chair and Afternoon Moderator, Associate Professor (CHS), University of Wisconsin‐Madison School of Pharmacy, Madison, Wisconsin

Anne Rose, PharmD, University of Wisconsin Hospitals and Clinics, Madison, WI

Maureen A. Smythe, PharmD, FCCP, Maureen Smythe, PharmD, FCCP, Professor (Clinical), Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, William Beaumont Hospital, Royal Oak, MI

Lynda Thomson, PharmD, Clinical Pharmacist, Thomas Jefferson University, Philadelphia, PA

Planning Committee

2019 Planning Committee

David S. Adler, PharmD, University of California, San Francisco and San Diego, CA
Kate P. Cabral, PharmD, Albany College of Pharmacy and Health Sciences, Albany, NY
Nathan P. Clark, PharmD, FCCP, BCPS, Kaiser Permanente Colorado, Aurora, CO
William E. Dager, PharmD, UC Davis Medical Center, Sacramento, CA
John Fanikos, RPh, MBA, Brigham and Women’s Hospital, Boston, MA
Michael P. Gulseth, PharmD, Sanford USD Medical Center, Sioux Falls, SD
Cynthia Jackevicius, PharmD, MSc, BCPS, FCSHP, FAHA, Western University of Health Sciences, Pomona, CA, Program Chair
Kenneth A. Kellick, PharmD, VA Western NY Healthcare System, Buffalo, NY
Brett Kelly, MS, BS Pharm, University of Wisconsin, Madison, WI, Conference Coordinator
Andrea L. Porter, PharmD, University of Wisconsin, Madison, WI, Conference Chair
Anne Rose, PharmD, University of Wisconsin Hospitals and Clinics, Madison, WI
Maureen A. Smythe, PharmD, FCCP, William Beaumont Hospital, Royal Oak, MI
Sarah A. Spinler, PharmD, Binghamton University School of Pharmacy and Pharmaceutical Studies, Binghamton, NY
Lynda Thomson, PharmD, Thomas Jefferson University, Philadelphia, PA

CE Credit

ICEP LogoIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

Accreditation Council for Pharmacy Education (ACPE)

A total of 7.0 hours of knowledge-based CE credit can be earned by successfully completing this activity.  CE credit information, based on verification of live attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.

AM Session ACPE# JA0000358-0000-19-068-L01-P (3.5 hours/0.35 CEU's)
PM Session ACPE# JA0000358-0000-19-1087-L01-P (3.5  hours/0.35 CEU's)

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.7 CEUs or 7 hours.

Program Coordinator

Brett Kelly, BS Pharm, MS

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 890-1886
brett.kelly@wisc.edu